# Depression-like Behavior Induced by Nesfatin-1 in Rats: Involvement of Increased Immune Activation and Imbalance of Synaptic Vesicle Proteins

**Authors:** Jin-Fang Ge, Ya-Yun Xu, Gan Qin, Yao-Nan Peng, Chao-Feng Zhang, Xing-Rui Liu, Li-Chuan Liang, Zhong-Zheng Wang, Fei-Hu Chen

PMC · DOI: 10.3389/fnins.2015.00429 · 2015-11-10

## TL;DR

Nesfatin-1, when injected into rats, causes depression-like behaviors linked to immune activation and changes in brain proteins related to synapses.

## Contribution

This study reveals a novel link between nesfatin-1, immune activation, and synaptic protein imbalance in depression-like behavior in rats.

## Key findings

- Chronic nesfatin-1 administration increases immobility in the forced swimming test and HPA axis activity.
- Nesfatin-1 elevates plasma IL-6 and CRP levels, correlating with depression-like behaviors and synaptic protein mRNA expression.
- Chronic nesfatin-1 reduces exploratory behavior and increases synapsin I and synaptotagmin I mRNA in the hypothalamus.

## Abstract

Depression is a multicausal disorder and has been associated with metabolism regulation and immuno-inflammatory reaction. The anorectic molecule nesfatin-1 has recently been characterized as a potential mood regulator, but its precise effect on depression and the possible mechanisms remain unknown, especially when given peripherally. In the present study, nesfatin-1 was intraperitoneally injected to the rats and the depression-like behavior and activity of the hypothalamic-pituitary-adrenal (HPA) axis were evaluated. The plasma concentrations of nesfatin-1, interleukin 6 (IL-6), and C-reactive protein (CRP); and the hypothalamic expression levels of nesfatin-1, synapsin I, and synaptotagmin I mRNA were evaluated in nesfatin-1 chronically treated rats. The results showed that both acute and chronic administration of nesfatin-1 increased immobility in the forced swimming test (FST), and resulted in the hyperactivity of HPA axis, as indicated by the increase of plasma corticosterone concentration and hypothalamic expression of corticotropin-releasing hormone (CRH) mRNA. Moreover, after chronic nesfatin-1 administration, the rats exhibited decreased activity and exploratory behavior in the open field test (OFT) and increased mRNA expression of synapsin I and synaptotagmin I in the hypothalamus. Furthermore, chronic administration of nesfatin-1 elevated plasma concentrations of IL-6 and CRP, which were positively correlated with despair behavior, plasma corticosterone level, and the hypothalamic mRNA expression of synapsin I and synaptotagmin I. These results indicated that exogenous nesfatin-1 could induce the immune-inflammatory activation, which might be a central hug linking the depression-like behavior and the imbalanced mRNA expression of synaptic vesicle proteins in the hypothalamus.

## Linked entities

- **Proteins:** Nucb2 (nucleobindin 2), IL6 (interleukin 6)
- **Diseases:** depression (MONDO:0002050)
- **Species:** Rattus norvegicus (taxon 10116)

## Full-text entities

- **Genes:** INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, Crp (C-reactive protein, pentraxin-related) [NCBI Gene 12944], Crebbp (CREB binding lysine acetyltransferase) [NCBI Gene 54244] {aka CBP, RSTS, RTS}, Nucb2 (nucleobindin 2) [NCBI Gene 53322] {aka Calnuc, Nefa, Nesfatin-1}, Crh (corticotropin releasing hormone) [NCBI Gene 81648] {aka CRF}, Syn1 (synapsin I) [NCBI Gene 24949], Actb (actin, beta) [NCBI Gene 81822] {aka Actx}, Syt1 (synaptotagmin 1) [NCBI Gene 25716] {aka P65}, Tnf (tumor necrosis factor) [NCBI Gene 24835] {aka RATTNF, TNF-alpha, Tnfa}, Nucb2 (nucleobindin 2) [NCBI Gene 59295] {aka Nefa, p54}, Crp (C-reactive protein) [NCBI Gene 25419] {aka Aa1249, Ab1-341, Ab2-196, Ac1-114, Ac1262, Ac2-069}, NUCB2 (nucleobindin 2) [NCBI Gene 4925] {aka HEL-S-109, NEFA}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, Il6 (interleukin 6) [NCBI Gene 24498] {aka ILg6, Ifnb2}
- **Diseases:** inflammatory (MESH:D007249), type 2 diabetes mellitus (MESH:D003924), psychiatric disorders (MESH:D001523), metabolic disorder (MESH:D008659), major depressive disorder (MESH:D003865), immuno-inflammatory (MESH:D000163), fear (MESH:C000719212), HPA (MESH:D007029), Depression (MESH:D003866), anxiety (MESH:D001007)
- **Chemicals:** cholesterol (MESH:D002784), glucose (MESH:D005947), TC (MESH:D013667), FFA (MESH:D005230), triglycerides (MESH:D014280), TG (MESH:D013866), calcium (MESH:D002118), sucrose (MESH:D013395), CORT (MESH:D003345), lipid (MESH:D008055), Ca2+ (-), TRIzol (MESH:C411644), nitrogen (MESH:D009584), cortisol (MESH:D006854), saline (MESH:D012965), chloral hydrate (MESH:D002697), water (MESH:D014867)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC4639614/full.md

---
Source: https://tomesphere.com/paper/PMC4639614